| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,663,000 | 4,176,000 | 3,090,000 | | Cost of Revenue | 2,699,000 | 2,453,000 | 1,777,000 | | | Gross Profit | 1,964,000 | 1,723,000 | 1,313,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 590,000 | 564,000 | 458,000 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| 8,000 | 3,000 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,374,000 | 1,151,000 | 852,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 101,000 | 175,000 | 84,000 | | Earnings Before Interest And Taxes | 1,475,000 | 1,326,000 | 936,000 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 1,475,000 | 1,326,000 | 936,000 | | Income Tax Expense | 194,000 | 171,000 | 84,000 | | Minority Interest |
-
|
-
| (2,000) | | | | Net Income From Continuing Ops | 1,281,000 | 1,155,000 | 850,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,281,000 | 1,155,000 | 850,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,281,000 | $1,155,000 | $850,000 |
|
0.29% Nasdaq 0.00%
Income Statement
